We will be at this years’ SITC conference!
Published on 18/10/2023
We are attending the SITC2023 Meeting (Society for Immunotherapy of Cancer, Booth No 638) in San Diego, CA the week of November 3-5 and are looking forward to meeting you there.
Learn about our role in peptide-driven, cell-based therapies and assays for immunology and cancer immunotherapy using our state-of-the-art peptide tools:
- PepMix peptide pools for cellular immune purposes (e.g. T cell assays and epitope discovery)
- We offer clinical (trial) grade peptides for immunotherapy approaches (e.g. gene transfer, vaccine developments etc.)
- PepStar peptide microarrays for seromarker discovery, humoral immune monitoring and antibody profiling
- Our high-throughput peptides are a cost-efficient option for broad discovery and screening purposes (antigen target, biomarker or neo-epitope discovery)
Besides our extensive catalog products, which cover multiple human tumor associated antigens, JPT prides itself to provide the largest variety of customizable peptide formats.
We will partner with you in your trial by providing knowledge and tools from neo-antigen and epitope discovery, to peptide vaccines, ex-vivo T cell expansion, and downstream monitoring of your clinical trial. Contact us to set-up a face-to-face meeting as we will be present throughout the entire conference.
See you there!